Yahoo
BSE - Delayed Quote INR

Resonance Specialties Limited (RESONANCE.BO)

297.75 +49.60 (+19.99%)
At close: November 9 at 3:57:52 PM GMT+5:30
Chart Range Bar
Loading chart for RESONANCE.BO
  • Previous Close 248.15
  • Open 245.85
  • Bid 297.75 x --
  • Ask --
  • Day's Range 245.85 - 297.75
  • 52 Week Range 77.00 - 297.75
  • Volume 179,966
  • Avg. Volume 32,283
  • Market Cap (intraday) 3.437B
  • Beta (5Y Monthly) 0.46
  • PE Ratio (TTM) 21.73
  • EPS (TTM) 13.70
  • Earnings Date (est.) --
  • Forward Dividend & Yield 1.00 (0.44%)
  • 1y Target Est --
  • Moby Rating Neutral

Resonance Specialties Limited engages in the manufacture and marketing of specialty chemicals in India and internationally. It offers pyridine, a chemical used in agrochemicals, pharmaceuticals, latexes, food, and allied industries, as well as to manufacture vitamins, medicines, food flavoring, dyes, adhesives, pesticides, herbicides, etc.; and picolines, including beta and gamma picolines used in manufacturing vinyl latex rubber, vitamin B3, and anti-tuberculosis drugs. The company also provides nutritional drug products, such as zinc and chromium picolinate, chromium polynicotinate, niacin, pyrazinamide and isoniazid; alpha picolinic and dipicolinic acids; solvents comprising acetonitrile and valeronitrile; and lutidines and collidines for anti-ulcer drugs. The company was formerly known as Armour Polymers Limited. Resonance Specialties Limited was incorporated in 1989 and is based in Mumbai, India.

www.resonancesl.com

74

Full Time Employees

March 31

Fiscal Year Ends

Chemicals

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

RESONANCE.BO
195.33%
S&P BSE SENSEX (^BSESN)
4.83%

1-Year Return

RESONANCE.BO
237.26%
S&P BSE SENSEX (^BSESN)
2.54%

3-Year Return

RESONANCE.BO
223.12%
S&P BSE SENSEX (^BSESN)
25.10%

5-Year Return

RESONANCE.BO
62.94%
S&P BSE SENSEX (^BSESN)
34.21%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    18.65%

  • Return on Assets (ttm)

    17.57%

  • Return on Equity (ttm)

    27.99%

  • Revenue (ttm)

    1.14B

  • Net Income Avi to Common (ttm)

    213.2M

  • Diluted EPS (ttm)

    13.70

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    211.43M

  • Total Debt/Equity (mrq)

    0.18%

  • Levered Free Cash Flow (ttm)

    157.6M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: